PubRank
Search
About
Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma
Clinical Trial ID NCT02051257
PubWeight™ 7.44
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT02051257
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Trial Watch: Adoptive cell transfer for anticancer immunotherapy.
Oncoimmunology
2014
0.96
2
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL.
Blood
2016
0.89
3
Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches.
Leukemia
2014
0.86
4
Trial Watch: Adoptive cell transfer for oncological indications.
Oncoimmunology
2015
0.84
5
Adoptive T-cell therapies for refractory/relapsed leukemia and lymphoma: current strategies and recent advances.
Ther Adv Hematol
2015
0.82
6
Targeting CD8+ T-cell tolerance for cancer immunotherapy.
Immunotherapy
2014
0.81
7
Challenges and opportunities of allogeneic donor-derived CAR T cells.
Curr Opin Hematol
2015
0.79
8
Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptors.
World J Stem Cells
2015
0.78
9
Management of patients with non-Hodgkin's lymphoma: focus on adoptive T-cell therapy.
Immunotargets Ther
2015
0.75
Next 100